+ All Categories
Home > Documents > Charles F. and Joanne Knight Alzheimer’s Disease Research...

Charles F. and Joanne Knight Alzheimer’s Disease Research...

Date post: 12-Aug-2020
Category:
Upload: others
View: 2 times
Download: 0 times
Share this document with a friend
6
Charles F. and Joanne Knight Alzheimer’s Disease Research Center (ADRC) Knight ADRC and the Memory & Aging Project Newsletter Volume 20(2) • Fall/wiNter 2013 DUO Program Enters 2nd Year The Knight ADRC Education Core is pleased that the Dementia Understanding Opportunity (DUO) Program has enrolled 10 students and 10 mentors for the 2013-2014 academic year. The DUO Program, in col- laboration with sister sites at Northwestern, Dartmouth, and Boston Universities, pairs 1st- and 2nd-year medical students with individuals with early stage Alzheimer’s disease for 2-hour monthly meetings throughout the academic year. The program helps students to learn about dementia and the effects on the patient and family, which are not typically covered in a textbook or clinical setting. In paents with early Alzheimer’s disease, disrupons in brain net - works emerge about the same me as chemical markers of the disease appear in the spinal fluid, research- ers at Washington University School of Medicine in St. Louis have shown. While two chemical markers in the spi- nal fluid are regarded as reliable indi- cators of early disease, the new study, published in JAMA Neurology, is among the first to show that scans of brain net - works may be an equally effecve and less invasive way to detect early disease. “Tracking damage to these brain networks may also help us for - mulate a more de- tailed understanding of what happens to the brain before the onset of demen- a,” said senior author Beau Ances, MD, PhD, associate professor of neu- rology and of biomedical engineering. Diagnosing Alzheimer’s early is a top priority for physicians, many of whom believe that treang paents long before demena starts greatly improves the chances of success. Ances and his colleagues studied 207 older but cognively normal research volunteers at the Charles F. and Joanne Knight Alzheimer’s Disease Research Center at Washington University. Over several years, spinal fluids from the volunteers were sampled mulple mes and analyzed for two markers of early Alzheimer’s: changes in amyloid Inside this Issue Naonal AD Plan Update ...... 2 AD Prevenon Drugs ............ 2 Honors. Awards, Funding ..... 3 Online Nutrion Resources .. 4 Mary Coats Rered............... 4 Goodwin Woolfolk Honored. 4 MAP Seeks Referrals............. 5 Summer & Fall in Review ...... 5 1 beta, the principal ingredient of Alzheim- er’s brain plaques, and in tau protein, a structural component of nerve cells. The volunteers were also scanned re- peatedly using a technique called rest - ing state funconal magnec resonance imaging (fMRI). This scan tracks the rise and fall of blood flow in different brain regions as paents rest in the scanner. Sciensts use the resulng data to as- sess the integrity of the default mode net - work, a set of connec- ons between differ - ent brain regions that becomes acve when the mind is at rest. Earlier studies by Ances and other researchers have shown that Al- zheimer’s damages con- necons in the default mode network and other brain networks. The new study revealed that this dam- age became detectable at about the same me that amyloid beta levels be- gan to fall and tau levels started to rise in spinal fluid. The part of the default mode network most harmed by the on- set of Alzheimer’s disease was the con- necon between two brain areas as- sociated with memory, the posterior cingulate and medial temporal regions. The researchers are connuing to study the connecons between brain net - work damage and the progress of early Alzheimer’s disease in normal volun- teers and in paents in the early stages of Alzheimer’s-associated demena. Arcle courtesy of Michael Purdy, Washington University School of Medicine. Brain Network Decay Detected in Early Alzheimer’s
Transcript
Page 1: Charles F. and Joanne Knight Alzheimer’s Disease Research ...knightadrc.wustl.edu/About_Us/Newsletter/Horizons Fall...Charles F. and Joanne Knight Alzheimer’s Disease Research

Charles F. and Joanne Knight Alzheimer’s Disease Research Center (ADRC)

Knight ADRC and the Memory & Aging Project

Newsletter • Volume 20(2) • Fall/wiNter 2013

DUO Program Enters 2nd YearThe Knight ADRC Education Core is pleased that the Dementia Understanding Opportunity (DUO) Program has enrolled 10 students and 10 mentors for the 2013-2014 academic year. The DUO Program, in col-laboration with sister sites at Northwestern, Dartmouth, and Boston Universities, pairs 1st- and 2nd-year medical students with individuals with early stage Alzheimer’s disease for 2-hour monthly meetings throughout the academic year. The program helps students to learn about dementia and the effects on the patient and family, which are not typically covered in a textbook or clinical setting.

In patients with early Alzheimer’s disease, disruptions in brain net-works emerge about the same time as chemical markers of the disease appear in the spinal fluid, research-ers at Washington University School of Medicine in St. Louis have shown.

While two chemical markers in the spi-nal fluid are regarded as reliable indi-cators of early disease, the new study, published in JAMA Neurology, is among the first to show that scans of brain net-works may be an equally effective and less invasive way to detect early disease.

“Tracking damage to these brain networks may also help us for-mulate a more de-tailed understanding of what happens to the brain before the onset of demen-tia,” said senior author Beau Ances, MD, PhD, associate professor of neu-rology and of biomedical engineering.

Diagnosing Alzheimer’s early is a top priority for physicians, many of whom believe that treating patients long before dementia starts greatly improves the chances of success.

Ances and his colleagues studied 207 older but cognitively normal research volunteers at the Charles F. and Joanne Knight Alzheimer’s Disease Research Center at Washington University. Over several years, spinal fluids from the volunteers were sampled multiple times and analyzed for two markers of early Alzheimer’s: changes in amyloid

Inside this IssueNational AD Plan Update ...... 2

AD Prevention Drugs ............ 2

Honors. Awards, Funding ..... 3

Online Nutrition Resources .. 4

Mary Coats Retired ............... 4

Goodwin Woolfolk Honored . 4

MAP Seeks Referrals ............. 5

Summer & Fall in Review ...... 5

1

beta, the principal ingredient of Alzheim-er’s brain plaques, and in tau protein, a structural component of nerve cells.

The volunteers were also scanned re-peatedly using a technique called rest-ing state functional magnetic resonance imaging (fMRI). This scan tracks the rise and fall of blood flow in different brain regions as patients rest in the scanner. Scientists use the resulting data to as-

sess the integrity of the default mode net-work, a set of connec-tions between differ-ent brain regions that becomes active when the mind is at rest.

Earlier studies by Ances and other researchers have shown that Al-zheimer’s damages con-nections in the default

mode network and other brain networks.

The new study revealed that this dam-age became detectable at about the same time that amyloid beta levels be-gan to fall and tau levels started to rise in spinal fluid. The part of the default mode network most harmed by the on-set of Alzheimer’s disease was the con-nection between two brain areas as-sociated with memory, the posterior cingulate and medial temporal regions.

The researchers are continuing to study the connections between brain net-work damage and the progress of early Alzheimer’s disease in normal volun-teers and in patients in the early stages of Alzheimer’s-associated dementia. Article courtesy of Michael Purdy, Washington University School of Medicine.

Brain Network Decay Detected in Early Alzheimer’s

Page 2: Charles F. and Joanne Knight Alzheimer’s Disease Research ...knightadrc.wustl.edu/About_Us/Newsletter/Horizons Fall...Charles F. and Joanne Knight Alzheimer’s Disease Research

2

U.S. Department of Health and Human Services (HHS) released the National Plan to Address Alzheimer’s Disease: 2013 Update in June, a follow-up to the initial plan released in May 2012. The update reflects national progress towards accomplishing the goals set a year ago, as well as new and revised action steps.

The plan includes: finding ways to prevent and effec-tively treat Alzheimer’s disease by 2025; enhancing care for Alzheimer’s patients; expanding support for people with dementia and their families; improving public awareness; and carefully tracking data to support these efforts. The Plan was developed collaboratively by experts in aging and Alzheimer’s disease from federal, state, private and non-profit organizations.

“Over the past year, the Plan has provided a framework for the progress made to relieve the burden of demen-tia on individuals, families, our health care system and our economy,” HHS Secretary Kathleen Sebelius said.

“Researchers are expanding their work on preven-tion and treatment and we are getting clinicians the tools they need to help people with the disease. By enhancing collaboration between the public and pri-vate sectors, the Plan is breaking down walls that have prevented the sharing of expertise, data and resources needed to combat the disease and provide the best care possible.”

National Plan to Address Alzheimer’s Disease UpdatedHHS launched the widely praised website, www.alzheim-ers.gov to increase public awareness and connect people with a diagnosis and their caregivers with important resources. The site had more than 200,000 visits in the first ten months.

The update plan also identifies additional action steps that HHS and its partners will take. These include:

• A unified Alzheimer’s disease training curriculum for primary care providers will be developed to help deliver high-quality dementia care. Research-ers will investigate avoidable hospitalization and emergency department use among those with Alzheimer’s disease and the best interventions for reducing them.

• Detection of elder abuse and neglect will be ex-panded through aging networks and program pro-viders who work with the Alzheimer’s population.

• An expanded Dementia Capability Toolkit will be developed for state and local health networks to better help them provide dementia services in their communities.

For more information about Alzheimer’s disease, visit www.alzheimers.gov. To read the National Plan to Ad-dress Alzheimer’s Disease: 2013 Update, visit http://aspe.hhs.gov/daltcp/napa/NatlPlan2013.shtml

Knight ADRC New Additions:Abedalrazaq AlKukhun, Saudi Arabia (1 month); Eun Joo Chung, MD, South Korea (1 year); Fen Wang, MD, China (1 year); and Aihong Zhou, MD, China (1 year) - Visiting Interna-tional ScholarsMary Creech – Memory and Aging Project Nurse ClinicianTamara Donahue - DIAN-TU Research Nurse CoordinatorMary Downey-Jones – Research Patient CoordinatorDenise Ritter - Accounting/Purchasing Clerk Davis Ryman, MD, PhD – Knight ADRC Fellow in the DIAN-TUTreacy Williams – Memory and Aging Project Nurse Clinician

Fond Farewells:Carla Berdeaux - Memory and Aging Project Nurse ClinicianMary Coats – Memory and Aging Project Assistant Clinical Core Leader (see page 4)Bon Ku, MD - Visiting International Scholar (South Korea)Denise Levitch – DIAN TU Research Nurse CoordinatorNatalie Selsor - Research Patient Coordinator

Update on Drug Treatments for AD PreventionHave you ever wondered about the status of medi-cations to treat or prevent Alzheimer’s disease (AD), and why so many seemingly promising drugs do not ad-vance past clinical trials? Dr. John C. Morris, Director of the Knight ADRC and Princi-pal Investigator of the Memory and Aging Project, shared his perspective with The Dana Founation, a private philanthropic organization that supports brain research through grants, publications, and educational programs. Dr. Morris’ article, “Persis-tent Failure of ‘Disease-Modifying’ Drugs to Benefit Alzheimer Disease: Now What?” addresses three major factors behind the failure of these therapeutic agents. To read the article and learn more, visit the Dana Foundation website and article link at: https://www.dana.org/publications/Persistent_Failure_of _Disease-Modi-fying_Drugs_to_Benefit_Alzheimer_Disease__Now_What_/

Page 3: Charles F. and Joanne Knight Alzheimer’s Disease Research ...knightadrc.wustl.edu/About_Us/Newsletter/Horizons Fall...Charles F. and Joanne Knight Alzheimer’s Disease Research

3

Honors, Awards & Funding Beau Ances, MD, PhD was promoted to Associate Pro-fessor of Neurology. Randall J. Bateman, MD, Charles F. and Joanne Knight Distinguished Professor of Neurology, was awarded $6 million over four years from the National Institutes of Health for the Dominantly Inherited Alzheimer’s Net-work Trials Unit to support the first prevention trial for Alzheimer’s disease using anti-amyloid drugs.Tammie Benzinger, MD, PhD was honored with the Friedman Center for Aging’s 2013 Kopolow Award, which recognizes stellar contribu-tions to research in aging. Dr. Benzinger is a radiologist and leader of the Knight ADRC Imaging Core.Matt Brier, a MD/PhD can-didate in the Ances labo-ratory, received the best Oral Presentation Award at the Alzheimer’s Imag-ing preconference to the Alzheimer’s Association International Conference. His work “Functional Connectivity and Graph Theory in Preclinical Alzheimer’s Disease” was recently accepted by Neu-robiology of Aging.David Carr, MD, Depart-ment of Internal Medicine and Neurology, was cho-sen to receive the WUSM 2014 Distinguished Clini-cian Award. Carr was also appointed Clinical Director of the Division of Neuro-Rehabilitation in the Department of Neurology. Dr. Carr continues to serve as Medical Director of The Rehabili-tation Institute of St. Louis. In his new role, Dr. Carr will be responsible for coordinating clinical operations in Neuro-rehabilitation and integrating clinical activities more strongly with The Rehabilitation Institute. He will also be involved in mentoring clinical faculty and resi-dent physicians, as well as in the development of novel clinical programs and outreach activities. Dr. Carr was also appointed the Director of the Knight ADRC African-American Outreach Satellite.Becky Fierberg, MSW, LCSW received the 2013 Fried-man Award from the Friedman Center for Aging at Washington University. The award recognizes out-standing contributions to the care of older adults.

Fierberg is a social worker at the Memory and Aging Project and coordinates the Adult Children’s Study and other research opportunities for study participants.John C. Morris, MD was awarded the Washington Uni-versity School of Medicine Second Century Award. Giv-en annually, the award is the highest honor bestowed by the medical school and recognizes individuals whose long-term commitment and participation truly have made a difference, enabling the School of Medicine to look to the future with strength and confidence. Dr. Morris was presented the award on October 4, 2013 at

the Ritz-Carlton. On October 21-23, 2013, Dr. Morris pre-sented the keynote lecture at the 13th Eibsee Meeting on Cellular Mechanisms of Neurodegeneration in Mu-nich, Germany. Additionally, Dr. Morris was elected to the 2013-2015 American Acade-my of Neurology (AAN) Board of Directors and the AAN Institute Board of Directors.Erik Musiek, MD, PhD was promoted to Assistant Profes-sor of Neurology. Suzanne Schindler, MD, PhD participated in the highly competitive National Institute on Aging Summer Institute on Aging Research, held in Maryland. The institute pro-vides the opportunity to learn more about research on ag-ing, and only 32 participants are selected each year from a nationwide pool of applicants.

Congratulations also to Dr. Schindler for passing her American Board of Psychiatry and Neurology certification exam.Chengjie Xiong, PhD, Knight ADRC Biostatistics Core Leader, was promoted to Professor of Biostatistics.

Mark Your 2014 CalendarAnnual State of the Knight ADRC Address

Tuesday, June 10, 2014, Noon - 1:00 pm

Connor Auditorium in the Farrell Learning and Teach-ing Center, Washington University Medical School

Delivered by John C. Morris, MD, Director and Principal Investigator, Knight ADRC

Davis Ryman, MD, PhD, Knight ADRC Fellow working under the mentorship of Randall Bateman, MD, in the DIAN Trials Unit, is the recipient of the 2013 Poletsky Award. Dr. Ryman was selected for his academic ac-complishments, current and potential future impact on the study of aging and dementia, and involvement in Knight ADRC activities. Dr. Ryman was presented with a $1,000 award to enhance ongoing educational and career development. Pictured from left to right:

Bateman, Ryman, Mildred Poletsky, and John C. Morris, MD.

Page 4: Charles F. and Joanne Knight Alzheimer’s Disease Research ...knightadrc.wustl.edu/About_Us/Newsletter/Horizons Fall...Charles F. and Joanne Knight Alzheimer’s Disease Research

Coats’ Retirement Brings Change to Knight ADRC

Since 1986, Mary Coats has been a fixture as senior nurse clinican in the Memory and Aging Project. Mary retired as of November 4, 2013, but fortuneately will continue with MAP as a part-time clinician. Her numer-ous leadership responsibilities have been divided between current MAP nurse clinicians. Angela Oliver will assume the role of Assistant Clinical Core Leader, and Pamela Millsap is the new Clinical Operations Manager. Everyone here at the center will be working together to fill Mary’s shoes.

Mary Coats and Jan McGillick, MA, Education Directior of the Alzheimer’s

Association-St. Louis Chapter, pause for a photo during Mary’s retirement luncheon.

Where in the World is the Knight ADRC? Everywhere! Looking at the map to the left, you can see there are

people all over the world visit-ing the Knight ADRC website to access information, resources, and training to use the Clinical Dementia Rating (CDR) assess-ment. The CDR is the same interview we use during your annual Memory and Aging Project (MAP) visit. The scope is impressive. Any area shaded

in blue has accessed our website. Have you had a chance to visit our website? Go to http://alzheimer.wustl.edu/ to stay up-to-date with the latest Alzheimer’s research news, clinical trials, and center events of interest to you.

4

Do You Know Someone with Memory Problems? Memory disorders are increasingly common as our population ages. At pres-ent, we have only a limited understanding of the difference between age-related memory complaints and memory deficits caused by illnesses such as Alzheimer disease. The Memory and Aging Project seeks older adult volun-teers to participate in a study on memory and thinking. Volunteers must be:

• 65 years or older• Have a general history of good health• Have mild memory loss for one year or longer• Able to participate in 2-3 visits on an annual basis• Have a family member or close friend to serve as co-participant

We also welcome healthy volunteers over age 55 whose parents were unaf-fected by dementia and lived past age 70.

There is no cost to participate. Volunteers receive a thorough assessment of memory and thinking each year by an experienced clinician. Study procedures include a blood draw, brain imaging studies, and a lumbar puncture.

Contact Volunteer for Health, (314) 362-1000, 1-866-362-5656 toll free, vfh.wustl.edu This research is not a substitute for your regular doctor’s visits. Di-rector: John C. Morris, MD.

Online Nutrition Resource AvailableHealthy eating is important at any age. It can be especially valuable to sup-port healthy cognition as you age. The National Institute on Aging offers an online nutrition resource that is full of information to help older adults make good food choices every day. Explore What’s On Your Plate? for videos and practical tips to help older adults live healthy lives. The dynamic website features topics like:• recommended eating plans• shopping for food that’s good for you, even on a tight budget• safely preparing, handling, and storing food• printable resources to use on-the-go or share with othersCheck it out online at: http://www.nia.nih.gov/health/publication/whats-your-plate

Congratulations to Knight ADRC Af-rican American Advisory Board Chair Ida Goodwin Woolfolk who received the Monsanto Family YMCA Lifetime Achievement Award at the Tuxedo & Tennis Gala on November 23, 2013.

The award recognizes an individual who is committed to serving the community

with dignity and integrity.

Ms. Woolfolk served the Saint Louis Public Schools for more than 38 years and is a nationally recognized consul-tant and speaker on diversity, stress management and communication.

Through her leadership and member-ship in countless service organizations, Ms. Woolfolk strives to build a better

future for all.

Page 5: Charles F. and Joanne Knight Alzheimer’s Disease Research ...knightadrc.wustl.edu/About_Us/Newsletter/Horizons Fall...Charles F. and Joanne Knight Alzheimer’s Disease Research

5

Summer and Fall 2013 in Review

The Knight ADRC was pleased to host a group of visiting Taiwanese neurologists in July. The group was led by former Knight ADRC Interna-tional Scholar Yuan-Han Yang, MD, MS, PhD. The visit also opened doors for a new partnership with the Mentality Protection Center, an outreach and edu-cation initiative of the Fo Guang Shan Buddhist Temple, St. Louis Branch.

The Knight ADRC made a strong showing in late August at the Walk to End Alzheimer’s Disease spon-sored by the Alzheimer’s Association. Despite record heat for the event, we were thrilled with the overwhelm-ing participation on the Knight ADRC / MIR Team, which included 138 walk-ers who raised $6,893 to fund Alzheimer services and research.

After an extensive renovation spanning nearly a year, the Knight ADRC welcomed the medical school community to an Open House and tour in

June. Shown above at the open house (from left to right) Chan-cellor Mark Wrighton, PhD, John C. Morris, MD and Randall Bateman, MD.

The Links, Incorporated, St. Louis Chapter President Mary Thomas welcomed guests to

the luncheon.

In October, the African American Outreach Satellite and African American Advisory Board (AAAB) hosted two successful education and research awareness events. The 8th Annual Norman R. Seay Lecture featured Consuelo Wilkins, MD, Executive Director of the Meharry-Vanderbilt Alliance who presented “The Three Keys To Closing The Disparities Gap In Alzheimer’s Disease.” The event was followed by a reception sponsored by The Links, Incorporated, St. Louis Chapter. Following the Seay Lecture, the KADRC partnered again with The Links, Incorporated, St. Louis Chapter, Centene Corporation, and Home State Health Plan to host the “Alzheimer’s Disease: Unraveling the Mystery” luncheon at the Renaissance Hotel Saint Louis Airport. The event was a continuation of several

strategic outreach events aimed at engaging the St. Louis African American community in memory and aging research. The event was led by AAAB Chair and community leader Ida Goodwin Woolfolk, and featured talks from John C. Morris, MD; David Carr, MD; Con-suelo Wilkins, MD; Monica Parker, MD; Jocelyn Damper, Multicultural Outreach Coordi-nator, Alzheimer’s Association; and Sidney White and Ronald Gregory, African American Advisory Board Members and research supporters.

Dr. John C. Morris (far right) joins St. Louis Civil Rights Activist Norman R. Seay (front, center) and members

of The Links, Incorporated, St. Louis Chapter.

Keep up with the Knight ADRC and current reseach news on Facebook, Twitter, and online at http://alzheimer.wustl.edu/

Page 6: Charles F. and Joanne Knight Alzheimer’s Disease Research ...knightadrc.wustl.edu/About_Us/Newsletter/Horizons Fall...Charles F. and Joanne Knight Alzheimer’s Disease Research

nonprofit org.u.s. postage

paidst. Louis, Mo

perMit no. 4453

4488 Forest Park Avenue • Suite 130 • St. Louis, MO 63108 (314) 286-2683 • Fax 286-2763 • www.alzheimer.wustl.edu

HORIZONS is the newsletter of the Charles F. and Joanne Knight Alzheimer’s Disease Research Center (Knight ADRC) — a research program in the Depart-ment of Neurology, Washington University School of Medicine, funded by grants from the National Institute on Aging and private donations. The ADRC supports and promotes interdisciplinary research on Alzheimer’s Disease. The Memory & Aging Project (MAP) — the clinical research office of the Knight ADRC — provides expert clinical assessments of cognitive functioning in normal aging and dementia.

John C. Morris, MD, Director, KADRC; Director, MAP; Administration Core and Clinical Core Leader

Alison Goate, DPhil, Associate Director, KADRC; Genet-ics Core Leader

Eugene M. Johnson, PhD, Associate Director, KADRC

David M. Holtzman, MD, Associate Director, KADRC

Virginia Buckles, PhD, Executive Director, KADRC

Krista Moulder, PhD, Associate Executive Director, KADRC

Jason Hassenstab, PhD, Psychometric Leader

Nigel J. Cairns, PhD, FRCPath, Neuropathology Core Leader

Tammie Benzinger, MD, PhD, Imaging Core Leader

Chengjie Xiong, PhD, Data Management and Biostatis-tics Core Leader

Anne Fagan, PhD, Biomarker Core Leader

Andrea Denny, JD, MSSW, Education Core Leader


Recommended